GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » 5-Year Yield-on-Cost %

Maat Pharma (XPAR:MAAT) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma 5-Year Yield-on-Cost %?

Maat Pharma's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Maat Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:



XPAR:MAAT's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.64
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Maat Pharma's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Maat Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maat Pharma's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Maat Pharma's 5-Year Yield-on-Cost % falls into.


;
;

Maat Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Maat Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Maat Pharma  (XPAR:MAAT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Maat Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Maat Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Maat Pharma Business Description

Traded in Other Exchanges
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines